Question 1

How does this study relate to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Evolution of the SURvival of Patients With SEzary Syndrome (SS) Over the 1998-2020 Period and Its Association With the Early Use of Therapeutic Monoclonal Antibodies clinical trial (NCT05206045). Contact the study team or your healthcare provider for specific answers.

Question 2

What are the potential benefits of participating in this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Evolution of the SURvival of Patients With SEzary Syndrome (SS) Over the 1998-2020 Period and Its Association With the Early Use of Therapeutic Monoclonal Antibodies clinical trial (NCT05206045). Contact the study team or your healthcare provider for specific answers.

Question 3

Will I receive any new treatments if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Evolution of the SURvival of Patients With SEzary Syndrome (SS) Over the 1998-2020 Period and Its Association With the Early Use of Therapeutic Monoclonal Antibodies clinical trial (NCT05206045). Contact the study team or your healthcare provider for specific answers.

Question 4

How will my health be monitored during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Evolution of the SURvival of Patients With SEzary Syndrome (SS) Over the 1998-2020 Period and Its Association With the Early Use of Therapeutic Monoclonal Antibodies clinical trial (NCT05206045). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I choose not to participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Evolution of the SURvival of Patients With SEzary Syndrome (SS) Over the 1998-2020 Period and Its Association With the Early Use of Therapeutic Monoclonal Antibodies clinical trial (NCT05206045). Contact the study team or your healthcare provider for specific answers.

What this study is about